The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Present and future medical applications of microbial exopolysaccharides
Open accessAbstract
Microbial exopolysaccharides (EPS) have found outstanding medical applications since the mid-20th century, with the first clinical trials on dextran solutions as plasma expanders. Other EPS entered medicine firstly as conventional pharmaceutical excipients (e.g., xanthan - as suspension stabilizer, or pullulan - in capsules and oral care products). Polysaccharides, initially obtained from plant or animal sources, became easily available for a wide range of applications, especially when they were commercially produced by microbial fermentation. Alginates are used as anti-reflux, dental impressions, or as matrix for tablets. Hyaluronic acid and derivatives are used in surgery, arthritis treatment, or wound healing. Bacterial cellulose is applied in wound dressings or scaffolds for tissue engineering. The development of drug controlled-release systems and of micro- and nanoparticulated ones, has opened a new era of medical applications for biopolymers. EPS and their derivatives are well-suited potentially non-toxic, biodegradable drug carriers. Such systems concern rating and targeting of controlled release. Their large area of applications is explained by the available manifold series of derivatives, whose useful properties can be thereby controlled. From matrix inclusion to conjugates, different systems have been designed to solubilize, and to assure stable transport in the body, target accumulation and variable rate-release of a drug substance. From controlled drug delivery, EPS potential applications expanded to vaccine adjuvants and diagnostic imaging systems. Other potential applications are related to the bioactive (immunomodulator, antitumor, antiviral) characteristics of EPS. The numerous potential applications still wait to be developed into commercial pharmaceuticals and medical devices. Based on previous and recent results in important medical-pharmaceutical domains, one can undoubtedly state that EPS medical applications have a broad future ahead.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polysaccharides-based nanoparticles as drug delivery systems
Liu, Z., Jiao, Y., Wang, Y., Zhou, C., & Zhang, Z. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.001 · Cited by 1,732
Hyaluronic acid: a natural biopolymer with a broad range of biomedical and industrial applications
Kogan, G., Šoltés, L., Stern, R., & Gemeiner, P. (2006) · Biotechnology Letters · doi:10.1007/s10529-006-9219-z · Cited by 1,000
Hyaluronic acid (hyaluronan): A review
Necas, J., Bartosikova, L., Brauner, P., & Kolar, J. (2008) · Veterinární medicína · doi:10.17221/1930-vetmed · Cited by 998
Advances in bacterial exopolysaccharides: from production to Biotechnological applications
Freitas, F., Alves, V. D., & Reis, M. A. M. (2011) · Trends in Biotechnology · doi:10.1016/j.tibtech.2011.03.008 · Cited by 804
Bacterial Exopolysaccharides: Functionality and Prospects
Nwodo, U. U., Green, E., & Okoh, A. I. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131114002 · Cited by 684
Anticancer polysaccharides from natural resources: A review of recent research
Zong, A., Cao, H., & Wang, F. (2012) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2012.07.026 · Cited by 669
Tassa, C., Shaw, S. Y., & Weissleder, R. (2011) · Accounts of Chemical Research · doi:10.1021/ar200084x · Cited by 653
Interpenetrating Polymer Networks polysaccharide hydrogels for drug delivery and tissue engineering
Matricardi, P., Di Meo, C., Coviello, T., Hennink, W. E., & Alhaique, F. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.04.002 · Cited by 553
Present status and applications of bacterial cellulose-based materials for skin tissue repair
Fu, L., Zhang, J., & Yang, G. (2013) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2012.10.071 · Cited by 523
Biosynthesis, production and applications of bacterial cellulose
Lin, S.-P., Loira Calvar, I., Catchmark, J. M., Liu, J.-R., Demirci, A., & Cheng, K.-C. (2013) · Cellulose · doi:10.1007/s10570-013-9994-3 · Cited by 473
Cited by
Nano based drug delivery systems: recent developments and future prospects
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodriguez-Torres, M. D. P., Acosta-Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0392-8 · Cited by 6,684
Polycyclic Aromatic Hydrocarbons: Sources, Toxicity, and Remediation Approaches
Patel, A. B., Shaikh, S., Jain, K. R., Desai, C., & Madamwar, D. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.562813 · Cited by 1,340
Microbial extracellular polymeric substances in the environment, technology and medicine
Flemming, H.-C., van Hullebusch, E. D., Little, B. J., Neu, T. R., Nielsen, P. H., Seviour, T., Stoodley, P., Wingender, J., & Wuertz, S. (2025) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01098-y · Cited by 420
Rahbar Saadat, Y., Yari Khosroushahi, A., & Pourghassem Gargari, B. (2019) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2019.04.025 · Cited by 370
Jurášková, D., Ribeiro, S. C., & Silva, C. C. G. (2022) · Foods · doi:10.3390/foods11020156 · Cited by 342
Metadata
- Authors
- Moscovici, M.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2015-09-29
- Volume
- 6
- Pages
- 1012-1012
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W1768583667
- Cited by
- 331
- References
- 84
- FWCI
- 16.31
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Present and future medical applications of microbial exopolysaccharides. https://app.cochat.ai/papers/10.3389/fmicb.2015.01012
- The paper
- Moscovici, M. (2015). Present and future medical applications of microbial exopolysaccharides. Frontiers in Microbiology. https://doi.org/10.3389/fmicb.2015.01012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.